In vitro activity of caspofungin against planktonic and sessile Candida sp. cells

• Autorzy: Serefko A , Chudzik B. , Malm A.
• Języki publikacji: EN

Abstrakty

EN

Candida sp. may be regarded as one of the leading etiologic agents of hospital-acquired infections, including those related with the indwelling medical devices, which become colonized by the yeasts, accompanied by biofilm formation. In this paper we assayed in vitro susceptibility to caspofungin of planktonic and sessile cells of nasopharyngeal isolates of Candida sp. Two types of biomaterials were used - silicone elastomer-coated latex urinary Foley catheter and PCV Thorax catheter. The minimal inhibitory concentrations (MIC) of caspofungin for planktonic Candida sp. cells ranged from 0.008 to 0.031 mg/l, while the minimal fungicidal concentrations (MFC) from 0.008 to 0.062 mg/l, with MFC/MIC ratios ≤2. The minimal concentration of caspofungin preventing adhesion process of Candida sp. on both biomaterials ranged from 0.004 to 0.031 mg/l, while preventing biofilm formation from 0.004 to 0.062 mg/l. In contrast, much higher minimal concentrations of caspofungin were needed to eradicate the mature biofilm (0.25 to >8 mg/l). In all cases, drug concentrations depended on the strain and the biomaterial used. Our preliminary data suggest that caspofungin, showing good anti-adherent activity in vitro against Candida sp., appears to be a potential agent rather for prophylaxis of the yeast infections associated with biomaterials but not for their treatment.

Słowa kluczowe

EN

yeast; agent; biomaterial; hospital-acquired infection; caspofungin; Candida; biofilm

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2006
• Tom: 55
• Numer: 2
• Opis fizyczny: p.133-137,fig.,ref.

Twórcy

autor

Serefko A

• Medical University of Lublin, Chodzki 1, 20-093 Lublin, Poland

autor

Chudzik B.

autor

Malm A.

Bibliografia

• Bachmann S.P., K. Vande Walle, G. Ramage, T.F. Patterson, B.L. Wickes, J.R. Graybill and J.L. Lopez-Ribot. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicroh. Agents Chemother. 46: 3591-3596.
• Bartizal C. and F.C. Odds. 2003. Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus. Antimicroh. Agents Chemother. 47: 2100-2107.
• Chandra J., D.M. Kuhn, P.K. Mukherjee, L.L. Hoyer, T. McCormick and M.A. Ghannoum. 2001. Bio-film formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacterial. 183: 5385-5394.
• Chryssanthou E. and M. Cuenca-Estrella. 2002. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. J. Clin. Microbiol. 40: 3841-3844.
• Douglas L.J. 2002. Medical importance of biofilms in Candida infections. Rev. Iberoam. Micol. 19: 139-143.
• Hawser S.P. and L.J. Douglas. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62: 915-921.
• Jabra-Rizk M.A., W.A. Falkler and T.F. Meiller. 2004. Fungal biofilms and drug resistance. Emerg. Infect. Dis. 10: 14-19.
• Kuhn D.M., T. George, J. Chandra, P.K. Mukherjee and M.A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46: 1773-1780.
• Letscher-Bru V. and R. Herbrecht. 2003. Caspofungin: the first representative of a new antifungal class. J. Antimicroh. Chemother. 51: 513-521.
• Levitz S.M. and D. Diamond. 1985. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J. Infect. Dis. 152: 938-944.
• Lindahl M., A. Farias, T. Wadstrom and S. Hjerten. 1981. A new test based on "salting out" to measure relative surface hydrofobicity of bacterial cells. Biochem. Biophys. Acta 677: 471-476.
• Ramage G., K. Vande Walle, S.P. Bachmann, B.L. Wickes and J.L. Lopez-Ribot. 2002. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicroh. Agents Chemother. 46: 3634-3636.
• Stevens D.A., M. Espiritu and R. Parmar. 2004. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicroh. Agents Chemother. 48: 3407-3411.
• Soustre J., M.H. Rodier, S. Imbert-Bouyer, G. Daniaultand C. Imbert. 2004. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins. J. Antimicroh. Chemother. 53: 522-525.